Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors

Small molecule mesenchymal-epithelial transition (MET) inhibitors, such as crizotinib, capmatinib, and tepotinib, are treatment options for metastatic non-small cell lung cancer (NSCLC) in adult patients whose tumors have a mutation that leads to MET exon 14 skipping. In clinical trials, these MET i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishio, Makoto, Kato, Terufumi, Toyozawa, Ryo, Hida, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512730/
https://www.ncbi.nlm.nih.gov/pubmed/36087188
http://dx.doi.org/10.1007/s11523-022-00912-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512730/
https://www.ncbi.nlm.nih.gov/pubmed/36087188
http://dx.doi.org/10.1007/s11523-022-00912-y

Ejemplares similares